IceCure Medical (ICCM) Shares Outstanding (Diluted Average) (2020 - 2025)
IceCure Medical (ICCM) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $63.6 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 24.97% to $63.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63.6 million through Dec 2025, up 24.97% year-over-year, with the annual reading at $63.6 million for FY2025, 24.97% up from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 was $63.6 million at IceCure Medical, up from $50.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $63.6 million in Q4 2025, with the low at $28.5 million in Q4 2021.
- Average Shares Outstanding (Diluted Average) over 5 years is $45.1 million, with a median of $45.6 million recorded in 2023.
- The sharpest move saw Shares Outstanding (Diluted Average) soared 66.67% in 2021, then increased 11.48% in 2024.
- Over 5 years, Shares Outstanding (Diluted Average) stood at $28.5 million in 2021, then increased by 29.66% to $37.0 million in 2022, then increased by 23.29% to $45.6 million in 2023, then rose by 11.48% to $50.9 million in 2024, then grew by 24.97% to $63.6 million in 2025.
- According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $63.6 million, $50.9 million, and $45.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.